Skip to main content
Equibles

SJS Investment Consulting Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1894302 SYLVANIA, OH
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$29,305
-$21,689 QoQ
Shares Held
47
-28.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,168
of 1,329 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $1,414,824 across 170 Biotechnology names. REGN ranks #7 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SLS
SELLAS Life Sciences Group, Inc.
 40,000 $590,400
2 JAZZ
Jazz Pharmaceuticals plc
 840 $202,414
3 TNXP
Tonix Pharmaceuticals Holding Corp.
 10,204 $130,203
4 BMRN
Biomarin Pharmaceutical Inc
 877 $50,181
5 EXEL
Exelixis, Inc.
 821 $44,670
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 59 $29,306
7 REGN
Regeneron Pharmaceuticals, Inc.
This page 		47 $29,305
8 INCY
Incyte Corp
 208 $23,578

All Filings in REGN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,305 47
2026-03-31 $50,994 66
2025-12-31 $145,882 189
2025-09-30 $84,340 150
2025-03-31 $1,268 2
2024-12-31 $2,136 3
2024-09-30 $8,409 8
2024-06-30 $8,408 8
2024-03-31 $7,698 8
2023-12-31 $7,025 8
2023-09-30 $9,051 11
2023-06-30 $7,903 11
2023-03-31 $10,681 13
2022-12-31 $8,657 12
2022-09-30 $4,132 6
2022-03-31 $18,158 26